St. Jude Children’s Research Hospital believes no child should die in the dawn of life.
That means every child, everywhere.
of essential cancer medicines around the globe is inconsistent due to supply and demand issues and complicated regulations.
of medicines is threatened when governments and administrations favor lowest-cost bids.
of childhood cancer medicines is often excluded from budgets, creating financial hardship for families in low- and middle- income countries.
71% of low-income countries report general shortages in cancer medicines. At the 70th World Health Assembly, global health leaders adopted a new resolution. It called for better access to essential medicines and other measures for all with cancer.
Introducing the Global Platform for Access to Childhood Cancer Medicines
St. Jude and World Health Organization (WHO) are creating the platform to provide children with cancer with an uninterrupted supply of quality cancer medicines.
The platform will bring St. Jude, WHO, governments, the pharmaceutical industry, non-governmental organizations and the nonprofit sector together to ensure quality and effective medicines are available to treat childhood cancer. This effort will increase global visibility and predictability of the market for childhood cancer medicines.
In 6 years, approximately 120,000 children in low- and middle- income countries could benefit.